Grown Rogue International (GRUSF) EBITDA Margin (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly EBITDA Margin of 1.09% for Q1 2026, up 1101.0% year-over-year from 0.09% in Q1 2025, and up 112.52% quarter-over-quarter from 8.7% in Q4 2025.
Grown Rogue International (GRUSF) EBITDA Margin (2009 - 2026) Analysis & Trends
Grown Rogue International's EBITDA Margin history runs 17 years deep, the most recent figure standing at 1.09% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 1101.0% year-over-year to 1.09%; the TTM figure through Mar 2026 stood at 15.7% (down 1606.0% YoY), while the FY2025 annual figure was 1.83%, down 206.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 1.09%, up from 8.7% in the prior quarter.
- The five-year high for EBITDA Margin was 14.28% in Q1 2023, with the low at 15.7% in Q2 2025.
- The 5-year median for EBITDA Margin is 7.38% (2023), against an average of 4.82%.
- The sharpest annual moves came in 2022 and 2026: EBITDA Margin plunged 8086 bps in 2022, then surged 1101 bps in 2026.
- Grown Rogue International's EBITDA Margin stood at 13.04% in 2022, then dropped by 10 bps to 11.71% in 2023, then slumped by 98 bps to 0.23% in 2024, then sank by 3960 bps to 8.7% in 2025, then soared by 113 bps to 1.09% in 2026.
- Business Quant data shows GRUSF's EBITDA Margin at 1.09% in Q1 2026, 8.7% in Q4 2025, and 6.83% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 8.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.42% |
| Mar 31, 2026 | 1.09% |
| Dec 31, 2025 | -8.70% |
| Sep 30, 2025 | 6.83% |
| Jun 30, 2025 | -15.70% |
| Mar 31, 2025 | -9.92% |
| Dec 31, 2024 | 0.23% |
| Sep 30, 2024 | 13.97% |
| Jun 30, 2024 | 1.65% |
| Mar 31, 2024 | 13.93% |
| Dec 31, 2023 | 11.71% |
| Oct 31, 2023 | 8.75% |
| Jul 31, 2023 | 7.38% |
| Apr 30, 2023 | 13.77% |
| Jan 31, 2023 | 14.28% |
| Jan 31, 2022 | 13.04% |
| Oct 31, 2021 | 40.30% |
| Jul 31, 2021 | 23.62% |
| Apr 30, 2021 | 9.27% |
| Jan 31, 2021 | 93.90% |